Clinical Trial: Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression


Official Title: Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression

Brief Summary:

The COVID-19 pandemic has led to a mis/disinformation ecosystem that promotes divergent views of vaccine efficacy, as well as the legitimacy of science and medicine.
Individuals are confronted with vaccine-related information from a multitude of sources, posing a challenge to identifying inaccurate information.
COVID-19 vaccine uptake is lower among people with anxiety and depression than in the general population, due in part to higher levels of vaccine hesitancy.
The prevalence of anxiety and depressive symptoms among US adults increased significantly during the COVID pandemic and has remained elevated.
Interventions capable of mitigating the impact of vaccine hesitancy and mis/disinformation among undervaccinated people with anxiety or depression are therefore an urgent priority.
Emerging evidence suggests that reasons for vaccine hesitancy and the impact of conventional vaccination messaging differ between those with and without mental health symptoms.
There may also be added challenges overcoming logistical barriers to vaccination for people with anxiety or depressive symptoms.

The investigators aim to determine the effectiveness of two different brief digital intervention strategies compared with conventional public health messaging for increasing vaccine uptake in undervaccinated adults with and without anxiety or depressive symptoms.
Attitudinal inoculation is a brief, scalable strategy that leverages the power of narrative, values, and emotion to strengthen resistance to mis/disinformation and reduce hesitancy.
Though this approach has been shown to decrease COVID-19 vaccine hesitancy among US adults, the extent to which this approach increases COVID-19 vaccination remains unknown.
Cognitive-behavioral therapy (CBT) is an evidence-based intervention for anxiety and depression.
However, the efficacy of incorporating CBT-informed messaging in a vaccine promotion intervention has not been tested.
The investigators hypothesize that both attitudinal inoculation and CBT-style communication will be more effective than conventional public health messaging to increase COVID-19 vaccination.
The investigators also hypothesize that the CBT-informed intervention will be more effective than the attitudinal inoculation intervention for increasing COVID-19 vaccination among participants with symptoms of anxiety or depression.